免疫介导炎症性疾病患者静脉血栓栓塞风险:英国匹配队列研究
基于英国RCGP RSC初级保健数据库1999–2019年数据,纳入53 378例免疫介导炎症性疾病(IMID)患者并匹配213 512例无IMID对照,采用Cox比例风险模型评估静脉血栓栓塞(VTE)风险。结果显示IMID患者VTE风险升高(aHR 1.46,95%CI 1.36–1.56),克罗恩病、溃疡性结肠炎和类风湿关节炎风险增加,银屑病关节炎无显著关联。
要点
- IMID患者VTE风险较匹配对照升高46%(aHR 1.46,95%CI 1.36–1.56)。
- 克罗恩病(aHR 1.74)、类风湿关节炎(aHR 1.54)、溃疡性结肠炎(aHR 1.27)VTE风险增加。
- 银屑病关节炎与VTE无显著关联(aHR 1.21,95%CI 0.96–1.52)。
核心结论
- IMID患者静脉血栓栓塞风险较匹配对照人群升高,且不同IMID病种风险存在差异。
研究设计与样本
- 英国RCGP RSC初级保健数据库1999–2019年匹配队列研究,纳入53 378例IMID患者和213 512例无IMID对照,采用Cox比例风险模型估计VTE风险。
主要发现
- IMID患者VTE风险升高(aHR 1.46,95%CI 1.36–1.56)。
- 克罗恩病VTE风险aHR 1.74(95%CI 1.45–2.08),溃疡性结肠炎aHR 1.27(95%CI 1.10–1.45),类风湿关节炎aHR 1.54(95%CI 1.40–1.70)。
- 银屑病关节炎与VTE无显著关联(aHR 1.21,95%CI 0.96–1.52)。
- IMID患者中VTE独立危险因素包括男性、超重/肥胖BMI、当前吸烟、骨折史及随访期间血小板计数异常。
临床怎么用
- 对IMID患者应关注VTE风险,可利用常规临床信息(如性别、BMI、吸烟、骨折史、血小板计数)识别高危个体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To describe the risk of venous thromboembolism (VTE), and risk factors for VTE, in people with immune-mediated inflammatory diseases (IMID) (ulcerative colitis, Crohn's disease (CD), rheumatoid arthritis (RA) and psoriatic arthritis (PsA)), compared with a matched control population. METHODS: A total of 53 378 people with an IMID were identified over 1999-2019 in the UK Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) primary care database and were matched to 213 512 people without an IMID. The association between the presence of any IMID, and each IMID separately, and risk of VTE was estimated using unadjusted and multivariable-adjusted Cox proportional hazards models. The prevalence of VTE risk factors, and associations between VTE risk factors and risk of VTE, were estimated in people with and without an IMID. RESULTS: People with an IMID were at increased risk of VTE (adjusted HR [aHR] 1.46, 95% CI 1.36,1.56), compared with matched controls. When assessing individual diseases, risk was increased for CD (aHR 1.74, 95% CI 1.45 to 2.08), ulcerative colitis (aHR 1.27, 95% CI 1.10 to 1.45) and RA (aHR 1.54, 95% CI 1.40 to 1.70) but there was no evidence of an association for PsA (aHR 1.21, 95% CI 0.96 to 1.52). In people with an IMID, independent risk factors for VTE included male sex, overweight/obese body mass index, current smoking, history of fracture, and, across study follow-up, abnormal platelet count. CONCLUSIONS: VTE risk is increased in people with IMIDs. Routinely available clinical information may be helpful to identify individuals with an IMID at increased future risk of VTE. OBSERVATIONAL STUDY REGISTRATION NUMBER: Clinicaltrials.gov (NCT03835780).
引用
- Galloway J, Barrett K, Irving P, et al. Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study. RMD Open. 2020. PMID: 32994362. doi:10.1136/rmdopen-2020-001392
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。